TRANSPOSON TARGETED INTEGRATION

$243,258P20FY2010RRNIH

University Of Hawaii At Manoa, Honolulu HI

Investigators

Linked publications & trials

Paper 37008716 Paper 34138411 Paper 34091350 Paper 29129945 Paper 28081710 Paper 27689733 Paper 27452440 Paper 26971289 Paper 26686989 Paper 26617977 Paper 26343828 Paper 26331426 Paper 25575491 Paper 25505806 Paper 25339735 Paper 25298198 Paper 25192059 Paper 25157324 Paper 24925925 Paper 24609977 Paper 24370662 Paper 24363888 Paper 24346234 Paper 24295156 Paper 24291777 Paper 24273355 Paper 24236721 Paper 24156938 Paper 24145137 Paper 24138138 Paper 24135962 Paper 23959137 Paper 23953131 Paper 23732930 Paper 23721877 Paper 23708234 Paper 23668937 Paper 23651272 Paper 23613954 Paper 23546885 Paper 23479730 Paper 23409198 Paper 23268326 Paper 23221478 Paper 23190013 Paper 23064117 Paper 23044819 Paper 23028772 Paper 22989489 Paper 22987791 Paper 22947416 Paper 22943788 Paper 22939376 Paper 22902292 Paper 22859899 Paper 22850207 Paper 22847956 Paper 22766373 Paper 22629193 Paper 22610997 Paper 22503726 Paper 22487427 Paper 22473598 Paper 22151602 Paper 22098319 Paper 22052202 Paper 21978950 Paper 21927512 Paper 21926172 Paper 21903139 Paper 21824077 Paper 21814047 Paper 21774591 Paper 21684854 Paper 21659607 Paper 21651822 Paper 21605011 Paper 21360284 Paper 21306896 Paper 21083502 Paper 20874413 Paper 20643931 Paper 20598369 Paper 20544603 Paper 20533755 Paper 20523726 Paper 20521393 Paper 20503891 Paper 20413646 Paper 20404201 Paper 19956354 Paper 19739598 Paper 19301474 Paper 18849439 Paper 18802106 Paper 18691759 Paper 18687253 Paper 18585419 Paper 18570229 Paper 18419187

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall goal of this application is to develop novel methods for producing transgenic animals, with an eventual emphasis for the techniques learned during these experiments to be applied in gene therapy.

View original record on NIH RePORTER →